Stifel Nicolaus Raises Astera Labs (NASDAQ:ALAB) Price Target to $200.00

Astera Labs (NASDAQ:ALAB) had its price target increased by research analysts at Stifel Nicolaus from $185.00 to $200.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ price target suggests a potential upside of 11.54% from the company’s previous close.

Other research analysts have also recently issued reports about the company. Needham & Company LLC lifted their price objective on Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a research report on Wednesday. Evercore ISI upped their price target on Astera Labs from $104.00 to $215.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 6th. Deutsche Bank Aktiengesellschaft upped their target price on Astera Labs from $160.00 to $200.00 and gave the stock a “buy” rating in a research note on Tuesday, September 2nd. Zacks Research lowered shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th. Finally, Wall Street Zen raised shares of Astera Labs from a “hold” rating to a “buy” rating in a research note on Monday. Twelve research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $171.06.

Astera Labs Stock Down 6.4%

ALAB stock opened at $179.31 on Wednesday. Astera Labs has a 12-month low of $47.13 and a 12-month high of $262.90. The business has a 50 day moving average of $196.79 and a 200-day moving average of $138.70. The firm has a market cap of $29.80 billion, a PE ratio of 320.20, a P/E/G ratio of 4.70 and a beta of 1.37.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.10. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm had revenue of $230.58 million for the quarter, compared to analysts’ expectations of $206.42 million. During the same quarter in the prior year, the firm posted $0.23 earnings per share. The business’s quarterly revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, research analysts expect that Astera Labs will post 0.34 earnings per share for the current year.

Insider Activity at Astera Labs

In related news, COO Sanjay Gajendra sold 280,000 shares of Astera Labs stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.02, for a total value of $47,605,600.00. Following the transaction, the chief operating officer owned 5,525,545 shares of the company’s stock, valued at approximately $939,453,160.90. This trade represents a 4.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total value of $31,708,410.00. Following the sale, the director directly owned 385,863 shares of the company’s stock, valued at approximately $66,858,482.01. The trade was a 32.17% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 1,092,997 shares of company stock worth $192,231,120 over the last 90 days. Company insiders own 12.50% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Oliver Lagore Vanvalin Investment Group bought a new stake in Astera Labs during the 2nd quarter worth about $29,000. Bernard Wealth Management Corp. bought a new position in Astera Labs in the 2nd quarter valued at approximately $36,000. Clearstead Trust LLC raised its position in Astera Labs by 46,100.0% during the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock worth $42,000 after purchasing an additional 461 shares during the last quarter. Advisors Asset Management Inc. boosted its position in shares of Astera Labs by 68.6% during the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after purchasing an additional 194 shares in the last quarter. Finally, Manchester Capital Management LLC raised its stake in Astera Labs by 141.5% during the 2nd quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock worth $44,000 after buying an additional 283 shares during the period. Institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.